Diagnosis of medullary thyroid cancer
Open Access
- 17 March 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (19)
- https://doi.org/10.3410/m1-19
Abstract
Diagnosis of medullary thyroid cancerThis publication has 17 references indexed in Scilit:
- Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid NodulesJournal of Clinical Endocrinology & Metabolism, 2006
- A Novel Point Mutation of theRETProtooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2004
- Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid DisordersJournal of Clinical Endocrinology & Metabolism, 2004
- Current diagnosis and management of medullary thyroid carcinomaAnnals of Oncology, 1998
- Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.Journal of Clinical Endocrinology & Metabolism, 1994
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHuman Molecular Genetics, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkageNature, 1987
- A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10Nature, 1987